Company / Operating Income
Neogen Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$37.5M
FY2025
5-year range
-$1.1B / $68.1M
FY2021-FY2025
Trend
+103.5%
vs FY2024
Sector context
#91 of 156
Health Care
What the data says
At $38M, Neogen's operating income ranks #91 of 156 in the Health Care sector. Operating Income returned to growth in FY2025 after 4 years of decline, reaching $38M.
Based on SEC 10-K filings.
$38M in FY2025 with a 5-year CAGR of -11.8%.
Declined from $59M to $38M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -17.8%
- 5-Year CAGR
- -11.8%
- 10-Year CAGR
- -
Sector benchmark
#91 of 156 in Health CareTop 58% of 156This company $37.5M Sector average $733.1M
▼
-94.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.8%, indicating a declining trend.
- In FY2025, operating income increased 103.5% year-over-year.
- Ranks #91 out of 156 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.86 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $37.5M | +103.5% |
| FY2024 | -$1.1B | -1908.6% |
| FY2023 | $58.7M | -13.1% |
| FY2022 | $67.5M | -0.8% |
| FY2021 | $68.1M | -3.0% |
| FY2020 | $70.2M | +8.1% |
| FY2019 | $64.9M | +15.2% |
| FY2018 | $56.4M | +6.2% |
| FY2017 | $53.1M | +22.4% |
| FY2016 | $43.4M | +6.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026